Ares Trading Sa opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Ares Trading Sa

Patent Number:
Title:
Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation
Applicant:
Opposition Date:
Mar 25, 2021
Patent Number:
Title:
Compositions And Methods For Targeted Immunomodulatory Antibodies And Fusion Proteins
Opposition Date:
Feb 2, 2018

Latest patents of Ares Trading Sa opposed by its competitors

Patent:
Grant Date:
Apr 22, 2020
Title:
Patient Care System Reporting Adherence To Treatment Regimen
Oppositions:
1
Patent:
Grant Date:
Aug 29, 2018
Title:
Use Of N-Acetyl-5-Methoxytryptamine Or Analogues Thereof, For Promoting The Mechanism Of Implantation Of The Embryo And Related Compositions And Culture Media
Oppositions:
1
Patent:
Grant Date:
Aug 22, 2018
Title:
Liquid Pharmaceutical Composition
Oppositions:
1
Patent:
Grant Date:
Jun 27, 2018
Title:
Liquid Pharmaceutical Composition
Oppositions:
2

Competitors of Ares Trading Sa

FERRING B.V.

AMGEN EUROPE B.V.

BIOGEN INC.

Want to track Ares Trading Sa?

Feel free to send us a message here and we will get back to you